MeSH term
Frequency | Condition_Probility | English Abstract | 4 | 0.0 |
European Continental Ancestry Group/*genetics | 5 | 1.0 |
Forensic Medicine | 4 | 6.0 |
*Genetics, Population | 21 | 5.0 |
Glucans/*genetics | 3 | 75.0 |
HLA-DQ Antigens/*genetics | 15 | 3.0 |
Humans | 60 | 0.0 |
Polymerase Chain Reaction | 19 | 0.0 |
Receptors, LDL/*genetics | 8 | 5.0 |
Alleles | 24 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Base Sequence | 6 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Polymorphism, Genetic/genetics | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 18 | 0.0 |
*Alleles | 11 | 0.0 |
Costa Rica | 2 | 15.0 |
Asian Continental Ancestry Group/*genetics | 2 | 0.0 |
DNA Fingerprinting/instrumentation/methods | 2 | 33.0 |
Discriminant Analysis | 3 | 3.0 |
Ethnic Groups/*genetics | 5 | 2.0 |
Gene Frequency/*genetics | 7 | 5.0 |
Heterozygote | 6 | 0.0 |
India | 2 | 0.0 |
Minisatellite Repeats/*genetics | 5 | 6.0 |
Blood Stains | 3 | 13.0 |
Chi-Square Distribution | 6 | 0.0 |
Comparative Study | 13 | 0.0 |
Genetic Markers/genetics | 5 | 1.0 |
Paternity | 5 | 6.0 |
Spain | 2 | 0.0 |
Adult | 6 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Dithiothreitol/pharmacology | 2 | 2.0 |
Female | 10 | 0.0 |
MNSs Blood-Group System | 2 | 40.0 |
Male | 10 | 0.0 |
Phenotype | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Polymorphism, Genetic | 10 | 0.0 |
Reference Values | 3 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Glycophorin/*genetics | 10 | 35.0 |
Immunoblotting | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Exons | 2 | 0.0 |
Japan | 5 | 0.0 |
MNSs Blood-Group System/*genetics/immunology | 2 | 100.0 |
DNA Fingerprinting/methods | 8 | 12.0 |
Homozygote | 4 | 0.0 |
Reproducibility of Results | 3 | 0.0 |
African Continental Ancestry Group/genetics | 4 | 1.0 |
Asian Continental Ancestry Group/genetics | 3 | 0.0 |
European Continental Ancestry Group/genetics | 5 | 0.0 |
*Gene Frequency | 17 | 3.0 |
DNA/*analysis | 11 | 5.0 |
Gene Frequency | 11 | 0.0 |
*Genetic Markers | 3 | 0.0 |
Receptors, LDL/genetics | 8 | 11.0 |
Databases, Factual | 2 | 0.0 |
Genotype | 23 | 0.0 |
Polymerase Chain Reaction/*methods | 9 | 1.0 |
Probability | 2 | 0.0 |
DNA/analysis | 5 | 0.0 |
Genetic Markers | 11 | 0.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
Glucans/genetics | 4 | 100.0 |
Glycophorin/genetics | 7 | 70.0 |
HLA-DQ Antigens/genetics | 5 | 1.0 |
Vitamin D-Binding Protein/genetics | 4 | 14.0 |
Reagent Kits, Diagnostic | 3 | 2.0 |
Vitamin D-Binding Protein/*genetics | 5 | 8.0 |
Gene Amplification | 6 | 0.0 |
Germany | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
*DNA Fingerprinting | 4 | 9.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Genetics, Population | 5 | 1.0 |
DNA Fingerprinting/*methods | 2 | 3.0 |
*Forensic Medicine | 3 | 7.0 |
*Chromosome Mapping | 2 | 0.0 |
Forensic Medicine/methods | 4 | 11.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Genetic Markers/*genetics | 6 | 5.0 |
Repetitive Sequences, Nucleic Acid/*genetics | 2 | 1.0 |
DNA/*blood | 3 | 9.0 |
Blood Proteins/*genetics | 2 | 1.0 |
Globins/genetics | 3 | 2.0 |
Korea | 2 | 0.0 |
Forensic Medicine/*methods | 2 | 6.0 |
HLA-DQ Antigens/analysis | 2 | 4.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Italy | 3 | 0.0 |
Hemoglobins, Abnormal/*genetics | 2 | 10.0 |
Spain/ethnology | 2 | 6.0 |
DNA Fingerprinting | 2 | 1.0 |
Likelihood Functions | 3 | 1.0 |
*Polymerase Chain Reaction | 5 | 2.0 |
United States | 2 | 0.0 |
Arabs/*genetics | 2 | 7.0 |
Hungary | 2 | 3.0 |
Indians, North American/*genetics | 2 | 2.0 |
Inuits/*genetics | 2 | 15.0 |
DNA/genetics | 3 | 0.0 |
Hemoglobins/genetics | 2 | 8.0 |
Gene Frequency/genetics | 2 | 0.0 |
*Genotype | 3 | 1.0 |
Reagent Kits, Diagnostic/*standards | 2 | 8.0 |
Hispanic Americans/genetics | 2 | 5.0 |
Models, Genetic | 2 | 0.0 |
Switzerland | 2 | 2.0 |
*Tandem Repeat Sequences | 3 | 2.0 |
Brazil | 2 | 0.0 |
Aged | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
